BRET BELTER: Open Payments
NPI 1578268751 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 18 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $387 · 2025 $333
Food & beverage: $314Education: $18
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Syndax Pharmaceuticals, Inc. | 1 | $23 |
| SERVIER PHARMACEUTICALS LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| BeOne Medicines USA, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| AVYXA PHARMA, LLC | 1 | $16 |
Products named: MONOFERRIC, Enhertu, LUPRON DEPOT, PLUVICTO, Tibsovo, Vyloy, BRUKINSA, LIBTAYO.
Industry payments across NE — which companies pay providers there.
